For treatment of: Bifidumbacterin intestines, immune system.Bifidumbacterin
- For the treatment of internal organs: intestines, immune system
- Appointment: pneumonia, dysbacteriosis, chronic diseases of the gastrointestinal tract, normalization of the intestinal microflora, gastrointestinal infections, treatment of food toxicoinfections (PTI), food and drug allergies
- Indications for use:
For oral administration
— prevention and treatment of gastrointestinal dysbiosis of various etiologies (including gastric and duodenal ulcers, pancreatitis, cholecystitis, hepatitis, allergic diseases, the appointment of antimicrobial drugs, hormones and NSAIDs);
— acute intestinal infections (shigellosis, salmonellosis, staphylococcal enterocolitis, rotovirus infection), food toxicoinfection, malabsorption syndrome, chronic constipation or diarrhea with prolonged antibacterial therapy;
— correction of microbiocenosis before and after operations on the intestines, liver, and pancreas;
— prevention of hospital infection and dysbiosis in patients who often suffer from SARS.
For local, intravaginal and rectal use
— urogenital tract dysbiosis, acute and chronic inflammatory diseases of the urogenital tract (including urogenital sexually transmitted infections - gonorrhea, urogenital chlamydia, genital herpes);
— bacterial vaginosis (gardnerellosis);
— non - specific colpitis (including hormone-dependent colpitis- senile);
— chronic colitis of various etiologies, intestinal dysfunction after acute intestinal infection;
— preparation for planned gynecological operations (for the prevention of postoperative infectious complications);
— prenatal training of pregnant women at risk for inflammatory diseases (for the prevention and treatment of vaginal dysbiosis).
Lyophilizate for the preparation of a solution for oral administration and topical use is used for the prevention of mastitis in nursing mothers at risk.
Congenital lactase deficiency. Glucose-galactose malabsorption.
Active substance: Bifidobacterium longum – 50000000 CFU